BioMarin Pharmaceutical Inc
BMRN
|
|
| |
|
| Trading Volume | 36,920 |
|
|
99.00 - 76.22 |
| Market Cap Full | $ 17.2B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 1.7% | -9.4% | -6% | -12.7% |
| Q2 | - | 1.7% | -10.9% | 7.5% |
| Q3 | - | 8.3% | 2.1% | 2.3% |
| Q4 | - | -1.5% | 10.7% | 22.1% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.7 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -8.7 | -2 | 1.2 | 1.5 | - | - | - | 8.3 | - | - | - | - |
| 2023 | |||||||||||
| 11.5 | -13.7 | -2.4 | -1.2 | -9.5 | -0.3 | 1.4 | 3.9 | -3.2 | -8 | 11.8 | 5.9 |
| 2022 | |||||||||||
| 0.3 | -11.9 | -1.3 | 5.5 | -7.7 | 10.3 | 3.8 | 4.2 | -5.4 | 2.2 | 16.6 | 2.5 |
| 2021 | |||||||||||
| -5.6 | -6.5 | -2.5 | 3.5 | -0.9 | 7.7 | -7.4 | 9 | -8.2 | 2.1 | 9.4 | 2.4 |
| 2020 | |||||||||||
| -2.7 | 8.2 | -4.8 | 8.9 | 15.8 | 15.8 | -2.9 | -34.5 | -3.1 | -2.2 | 5.7 | 11.5 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | 0.3 | 0.6 | 0.1 | 0.4 |
| Q2 | 0.3 | 0.2 | 0.1 | -0.2 |
| Q3 | 0.2 | -0 | -0.2 | 4 |
| Q4 | 0 | 0 | -0.3 | 0.2 |
| A | 0.77 | 0.8 | -0.4 | 4.5 |